Research reveals genetic factors in cerebral palsy development

A Canadian-led study has identified genes which may be partially responsible for the development of cerebral palsy.

Catalyst licenses Santhera Pharmaceuticals’ vamorolone

Vamorolone has received orphan drug status in the US to treat Duchenne muscular dystrophy. Credit: StudioMolekuul / shutterstock.com. Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed

June 20, 2023

Lilly Simplifies Chronic Disease Management with New Digital Platform: LillyDirect

What You Should Know: – Eli Lilly and Company (NYSE: LLY) announced today the launch of LillyDirect™, a comprehensive digital healthcare platform designed to empower

January 4, 2024

NIH launches $270 million anti-overdose research program for, and led by, Native Americans

Fatal drug overdoses shot up during the peak of Covid-19 in 2020. And as the dust settled on the pandemic, it quickly became clear that

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.